Announcements Trials
Browse Landscape

Phase

Phase NA 16Phase 3 3Phase 2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1

Conditions

Stomach Neoplasms 1Gynecologic Cancer 1Endometrial Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Enhanced Recovery After Surgery × Clear all
NCT06732635 2024-12-13

FAST-TRACK

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Phase 3 Completed
68 enrolled
Gynecologic

Endometrial Neoplasms

NCT04596800 2023-10-31

PROPER

Instituto Brasileiro de Controle do Cancer

Phase 3 Unknown
194 enrolled
Gynecologic

Gynecologic Cancer

NCT03160924 2020-05-22

The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy

Chinese University of Hong Kong

Phase 3 Unknown
50 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡